Nvidia Partners With Eli Lilly

Media Summary: AI is revolutionizing pharmaceuticals, moving from a side tool to a core driver of many aspects of the industry. David Bahnsen, The Bahnsen Group CIO, joins 'Power Lunch' to discuss stock play for three stocks. Market update for January 13, 2026 Follow us on Instagram () for bonus content and instant reactions.

Nvidia Partners With Eli Lilly - Detailed Analysis & Overview

AI is revolutionizing pharmaceuticals, moving from a side tool to a core driver of many aspects of the industry. David Bahnsen, The Bahnsen Group CIO, joins 'Power Lunch' to discuss stock play for three stocks. Market update for January 13, 2026 Follow us on Instagram () for bonus content and instant reactions.

Photo Gallery

Nvidia Partners With Eli Lilly on AI Drug Laboratory

NVIDIA & Lilly: The AI Revolution in Drug Discovery | Jensen Huang & David Ricks

Nvidia to Invest $1 Billion in AI Drug Laboratory With Eli Lilly

Nvidia to Invest $1 Billion in AI Drug Lab With Eli Lilly

Biomedical Intelligence at Scale with Lilly's AI Factory

NVIDIA’s $1 Billion Bet: Why Eli Lilly is Reinvigorating Pharma with AI

Biotech Series: Eli Lilly Chief AI Officer Thomas Fuchs on AI's Power to Transform Pharmaceuticals

S3:E9 - Reinventing Drug Discovery: Inside the Lilly and Nvidia AI Collaboration

3-Stock Lunch: Nvidia, Eli Lilly, Paramount

CPI Steady at 2.7%, Nvidia and Eli Lilly Announce $1B Partnership

View Detailed Profile

Nvidia Partners With Eli Lilly on AI Drug Laboratory

Nvidia Partners With Eli Lilly on AI Drug Laboratory

Nvidia

NVIDIA & Lilly: The AI Revolution in Drug Discovery | Jensen Huang & David Ricks

NVIDIA & Lilly: The AI Revolution in Drug Discovery | Jensen Huang & David Ricks

Highlights: 1.

Nvidia to Invest $1 Billion in AI Drug Laboratory With Eli Lilly

Nvidia to Invest $1 Billion in AI Drug Laboratory With Eli Lilly

Nvidia

Nvidia to Invest $1 Billion in AI Drug Lab With Eli Lilly

Nvidia to Invest $1 Billion in AI Drug Lab With Eli Lilly

Nvidia

Biomedical Intelligence at Scale with Lilly's AI Factory

Biomedical Intelligence at Scale with Lilly's AI Factory

Lilly

NVIDIA’s $1 Billion Bet: Why Eli Lilly is Reinvigorating Pharma with AI

NVIDIA’s $1 Billion Bet: Why Eli Lilly is Reinvigorating Pharma with AI

Eli Lilly

Biotech Series: Eli Lilly Chief AI Officer Thomas Fuchs on AI's Power to Transform Pharmaceuticals

Biotech Series: Eli Lilly Chief AI Officer Thomas Fuchs on AI's Power to Transform Pharmaceuticals

AI is revolutionizing pharmaceuticals, moving from a side tool to a core driver of many aspects of the industry.

S3:E9 - Reinventing Drug Discovery: Inside the Lilly and Nvidia AI Collaboration

S3:E9 - Reinventing Drug Discovery: Inside the Lilly and Nvidia AI Collaboration

Eli Lilly

3-Stock Lunch: Nvidia, Eli Lilly, Paramount

3-Stock Lunch: Nvidia, Eli Lilly, Paramount

David Bahnsen, The Bahnsen Group CIO, joins 'Power Lunch' to discuss stock play for three stocks.

CPI Steady at 2.7%, Nvidia and Eli Lilly Announce $1B Partnership

CPI Steady at 2.7%, Nvidia and Eli Lilly Announce $1B Partnership

Market update for January 13, 2026 Follow us on Instagram (@TheRundownDaily) for bonus content and instant reactions.

Related Video Content

Nvidia - Official Site information

Artificial Intelligence Computing Leadership from NVIDIA: inventor of the GPU, which creates interactive graphics on...

World Leader in Artificial Intelligence Computing | NVIDIA information

NVIDIA GeForce RTX™ powers the world’s fastest GPUs and the ultimate platform for gamers and creators. Enjoy...

Nvidia - Wikipedia information

Nvidia ... Nvidia Corporation[a] (/ ɛnˈvɪdiə / en-VID-ee-ə) is an American multinational technology company...

NVIDIA Corporation (NVDA) Stock Price, News, Quote & History information

Find the latest NVIDIA Corporation (NVDA) stock quote, history, news and other vital information to help you with...

GeForce NOW information

Instantly play the most demanding PC games and seamlessly play across your devices.